Metformin use is not associated with B12 deficiency or neuropathy in patients with type 2 diabetes Mellitus in Qatar

Tarik Elhadd, Georgios Ponirakis, Zeinab Dabbous, Mashhood Siddique, Subitha Chinnaiyan, Rayaz Malik

Research output: Contribution to journalArticle

Abstract

Background: Metformin may lead to B12 deficiency and neuropathy. There are no published data on the prevalence of Metformin-related B12 deficiency and neuropathy in the Arabian Gulf. Aims: Determine whether Metformin intake is associated with B12 deficiency and whether B12 deficiency is associated with diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy. Methods: Patients with type 2 diabetes mellitus (T2DM) (n = 362) attending outpatient clinics at HMC underwent assessment of B12 levels, the DN4 questionnaire, and vibration perception threshold (VPT). Results: Comparing Metformin to non-Metformin users there were no differences in B12 levels, VPT, or DN4. The prevalence of B12 deficiency (B12 < 133 pmol/l) was lower (P < 0.01) in Metformin (8%) compared to non-Metformin (19%) users. Patients with B12 deficiency had a comparable prevalence and severity of sensory neuropathy and painful neuropathy to patients without B12 deficiency. Conclusion: Serum B12 levels were comparable between Metformin and non-Metformin users with T2DM in Qatar. T2DM patients on Metformin had a lower prevalence of B12 deficiency. Furthermore, the prevalence and severity of neuropathy and painful diabetic neuropathy were comparable between patients with and without B12 deficiency.

Original languageEnglish
Article number248
JournalFrontiers in Endocrinology
Volume9
Issue numberMAY
DOIs
Publication statusPublished - 25 May 2018

Fingerprint

Qatar
Metformin
Type 2 Diabetes Mellitus
Diabetic Neuropathies
Vibration
Peripheral Nervous System Diseases
Ambulatory Care Facilities

Keywords

  • Diabetic neuropathy
  • Diabetic painful neuropathy
  • Metformin
  • Type 2 diabetes mellitus
  • Vitamin B12 deficiency

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Metformin use is not associated with B12 deficiency or neuropathy in patients with type 2 diabetes Mellitus in Qatar. / Elhadd, Tarik; Ponirakis, Georgios; Dabbous, Zeinab; Siddique, Mashhood; Chinnaiyan, Subitha; Malik, Rayaz.

In: Frontiers in Endocrinology, Vol. 9, No. MAY, 248, 25.05.2018.

Research output: Contribution to journalArticle

@article{3b54356e70cb436eb3ad91b3bf9ffa5d,
title = "Metformin use is not associated with B12 deficiency or neuropathy in patients with type 2 diabetes Mellitus in Qatar",
abstract = "Background: Metformin may lead to B12 deficiency and neuropathy. There are no published data on the prevalence of Metformin-related B12 deficiency and neuropathy in the Arabian Gulf. Aims: Determine whether Metformin intake is associated with B12 deficiency and whether B12 deficiency is associated with diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy. Methods: Patients with type 2 diabetes mellitus (T2DM) (n = 362) attending outpatient clinics at HMC underwent assessment of B12 levels, the DN4 questionnaire, and vibration perception threshold (VPT). Results: Comparing Metformin to non-Metformin users there were no differences in B12 levels, VPT, or DN4. The prevalence of B12 deficiency (B12 < 133 pmol/l) was lower (P < 0.01) in Metformin (8{\%}) compared to non-Metformin (19{\%}) users. Patients with B12 deficiency had a comparable prevalence and severity of sensory neuropathy and painful neuropathy to patients without B12 deficiency. Conclusion: Serum B12 levels were comparable between Metformin and non-Metformin users with T2DM in Qatar. T2DM patients on Metformin had a lower prevalence of B12 deficiency. Furthermore, the prevalence and severity of neuropathy and painful diabetic neuropathy were comparable between patients with and without B12 deficiency.",
keywords = "Diabetic neuropathy, Diabetic painful neuropathy, Metformin, Type 2 diabetes mellitus, Vitamin B12 deficiency",
author = "Tarik Elhadd and Georgios Ponirakis and Zeinab Dabbous and Mashhood Siddique and Subitha Chinnaiyan and Rayaz Malik",
year = "2018",
month = "5",
day = "25",
doi = "10.3389/fendo.2018.00248",
language = "English",
volume = "9",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S. A.",
number = "MAY",

}

TY - JOUR

T1 - Metformin use is not associated with B12 deficiency or neuropathy in patients with type 2 diabetes Mellitus in Qatar

AU - Elhadd, Tarik

AU - Ponirakis, Georgios

AU - Dabbous, Zeinab

AU - Siddique, Mashhood

AU - Chinnaiyan, Subitha

AU - Malik, Rayaz

PY - 2018/5/25

Y1 - 2018/5/25

N2 - Background: Metformin may lead to B12 deficiency and neuropathy. There are no published data on the prevalence of Metformin-related B12 deficiency and neuropathy in the Arabian Gulf. Aims: Determine whether Metformin intake is associated with B12 deficiency and whether B12 deficiency is associated with diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy. Methods: Patients with type 2 diabetes mellitus (T2DM) (n = 362) attending outpatient clinics at HMC underwent assessment of B12 levels, the DN4 questionnaire, and vibration perception threshold (VPT). Results: Comparing Metformin to non-Metformin users there were no differences in B12 levels, VPT, or DN4. The prevalence of B12 deficiency (B12 < 133 pmol/l) was lower (P < 0.01) in Metformin (8%) compared to non-Metformin (19%) users. Patients with B12 deficiency had a comparable prevalence and severity of sensory neuropathy and painful neuropathy to patients without B12 deficiency. Conclusion: Serum B12 levels were comparable between Metformin and non-Metformin users with T2DM in Qatar. T2DM patients on Metformin had a lower prevalence of B12 deficiency. Furthermore, the prevalence and severity of neuropathy and painful diabetic neuropathy were comparable between patients with and without B12 deficiency.

AB - Background: Metformin may lead to B12 deficiency and neuropathy. There are no published data on the prevalence of Metformin-related B12 deficiency and neuropathy in the Arabian Gulf. Aims: Determine whether Metformin intake is associated with B12 deficiency and whether B12 deficiency is associated with diabetic peripheral neuropathy (DPN) and painful diabetic neuropathy. Methods: Patients with type 2 diabetes mellitus (T2DM) (n = 362) attending outpatient clinics at HMC underwent assessment of B12 levels, the DN4 questionnaire, and vibration perception threshold (VPT). Results: Comparing Metformin to non-Metformin users there were no differences in B12 levels, VPT, or DN4. The prevalence of B12 deficiency (B12 < 133 pmol/l) was lower (P < 0.01) in Metformin (8%) compared to non-Metformin (19%) users. Patients with B12 deficiency had a comparable prevalence and severity of sensory neuropathy and painful neuropathy to patients without B12 deficiency. Conclusion: Serum B12 levels were comparable between Metformin and non-Metformin users with T2DM in Qatar. T2DM patients on Metformin had a lower prevalence of B12 deficiency. Furthermore, the prevalence and severity of neuropathy and painful diabetic neuropathy were comparable between patients with and without B12 deficiency.

KW - Diabetic neuropathy

KW - Diabetic painful neuropathy

KW - Metformin

KW - Type 2 diabetes mellitus

KW - Vitamin B12 deficiency

UR - http://www.scopus.com/inward/record.url?scp=85047527408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047527408&partnerID=8YFLogxK

U2 - 10.3389/fendo.2018.00248

DO - 10.3389/fendo.2018.00248

M3 - Article

AN - SCOPUS:85047527408

VL - 9

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

IS - MAY

M1 - 248

ER -